Skip to main content
SpringerLink
Log in

Nitric Oxide, Systemic Inflammatory Response Syndrome and Circulatory Shock

  • Conference paper
Symposium in Immunology VIII

  • 59 Accesses

Abstract

The medical syndrome of shock can be defined as a “progressive failure of the circulation to provide blood and oxygen to vital organs of the body”. In clinical practice, the key symptom of shock is a severe fall in blood pressure which is often associated with the dysfunction or failure of several important organs including lung, kidney, liver and brain. The most common cause of shock is the contamination of blood with bacteria (bacteremia), viruses, fungi or parasites, resulting in systemic infection and ultimately shock (septic shock). Other causes of shock include severe hemorrhage (hemorrhagic shock), trauma (traumatic shock), failure of the heart to maintain a sufficient cardiac output (cardiogenic shock), interruption of the innervation of blood vessels (neurogenic shock) and severe allergic reactions (anaphylactic shock). Septic shock, regardless of its aetiology, is defined as sepsis (systemic response to infection) with hypotension despite adequate fluid replacement, resulting in impaired tissue perfusion and oxygen extraction (Parrillo, 1990). The definition of septic shock is independent of the presence or absence of a multiple organ dysfunction syndrome (MODS), which is defined as impaired organ function such that homeostasis cannot be maintained without intervention (Baue, 1993). Primary MODS is a direct result of a well-defined insult to a specific organ.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arkovitz MS, Wispe JR, Garcia VF, Szabo C (1996) Selective inhibition of the inducible isoform of nitric oxide synthase prevents pulmonary transvascular flux during acute endotoxemia. J Pediatr Surg 31: 1009 – 1015

    Article  PubMed  CAS  Google Scholar 

  • Baue AE (1993) The multiple organ or systems failure syndrome. In: Schlag G, Redl H (eds) Pathophysiology of shock, sepsis and organ failure, Springer, Berlin, pp 1004 – 1018

    Google Scholar 

  • Billiar TR, Curran RD, Harbrecht BG, Stuehr DJ, Demetris AJ, Simmons RL (1990) Modulation of nitrogen oxide synthesis in vivo: NG-monomethyl-L-arginine inhibits endotoxin-induced nitrite/nitrate biosynthesis while promoting hepatic damage. J Leukoc Biol 48: 565 – 569

    PubMed  CAS  Google Scholar 

  • Boje KM (1996) Inhibition of nitric oxide synthase attenuates blood-brain barrier disruption during experimental meningitis. Brain Res 720: 75 – 83

    Article  PubMed  CAS  Google Scholar 

  • Booke M, Hinder F, McGuire R, Traber LD, Traber DL (1996a) Nitric oxide synthase inhibition versus norepinephrine for the treatment of hyperdynamic sepsis in sheep. Crit Care Med 24: 835 – 844

    Article  CAS  Google Scholar 

  • Booke M, Hinder F, McGuire R, Traber LD, Traber DL (1996b) Nitric oxide synthase inhibition versus norepinephrine in ovine sepsis: effects on regional blood flow. Shock 5: 362 – 370

    Article  CAS  Google Scholar 

  • Carnigie PR, Fellows FCI, Symington GR (1977) Urinary excretion of methylarginine

    Google Scholar 

  • in human disease. Metabolism 26:531–537

    Google Scholar 

  • Corbett JA, Tilton RG, Chang K, Hasan KS, Ido Y, Wang JL, Sweetland MA, Lancaster JR, Williamson JR, McDaniel ML (1992) Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552 – 558

    Article  PubMed  CAS  Google Scholar 

  • Dinerman JL, Lowenstein CJ, Snyder SH (1993) Molecular mechanism of nitric oxide regulation: potential relevance to cardiovascular disease. Circ Res 73: 217 – 222

    PubMed  CAS  Google Scholar 

  • Faraci WS, Nagel AA, Verdries KA, Vincent LA, Xu H, Nichols LE, Labasi JM, Salter ED, Pettipher ER (1996) 2-Amino-4-methylpyridine as a potent inhibitor of inducible NO synthase activity in vitro and in vivo. Br J Pharmacol 119:1101–1108

    Google Scholar 

  • Garvey EP, Oplinger J A, Furfine ES, Kiff RJ, Laszlo F, Whittle BJR, Knowles RG (1997) 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric oxide synthase in vitro and in vivo. J Biol Chem 272:4959–4963

    Google Scholar 

  • Garvey PE, Oplinger JA, Tanoury GJ, Sherman PA, Fowler M, Marshall S, Marmon MF, Paith JE, Furfine ES (1994) Potent and selective inhibition of human nitric oxide synthases. Inhibition by non-amino acid isothioureas. J Biol Chem 269: 26669 – 26676

    PubMed  CAS  Google Scholar 

  • Gross SS, Stuehr DJ, Aisaka K, Jaffe EA, Levi R, Griffith OW (1990) Macrophage and endothelial nitric oxide synthesis: cell-type selective inhibition by NG-aminoargi- nine, NG-nitroarginine and NG-methyl-arginine. Biochem Biophys Res Commun 170: 96 – 103

    Article  PubMed  CAS  Google Scholar 

  • Julou-Schaeffer G, Gray GA, Fleming I, Schott C, Parratt JR, Stoclet JC (1990) Loss of vascular responsiveness induced by endotoxin involves the L-arginine pathway. Am J Physiol 259: H1038 – 1043

    PubMed  CAS  Google Scholar 

  • Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF (1990) NG-methyl-L-arginine inhibits tumour necrosis factor-induced hypotension: implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 87: 3629 – 3632

    Article  PubMed  CAS  Google Scholar 

  • Kilbourn RG, Juburan A, Gross SS, Griffith OW, Levi R, Adams J (1990) Reversal of endotoxin-mediated shock by NG-monomethyl-L-arginine, an inhibitor of nitric oxide synthesis. Biochem Biophys Res Commun 172: 1132 – 1138

    Article  PubMed  CAS  Google Scholar 

  • Lorente JA, Landin L, De Pablo R, Renes E, Liste D (1993) L-arginine pathway in the sepsis syndrome. Crit Care Med 21: 1287 – 1295

    Article  PubMed  CAS  Google Scholar 

  • Loscalzo J, Welsch G (1995) Nitric oxide and its role in the cardiovascular system. Proj Cardiovascular Dis 38: 87 – 104

    Article  CAS  Google Scholar 

  • MacMicking JD, Nathan C, Horn G (1995) Altered responses to bacterial infection and endo toxic shock in mice lacking inducible nitric oxide synthase. Cell 82: 641 – 650

    Article  Google Scholar 

  • Meyer J, Lentz CW, Stothert JC, Traber LD, Herndon DN, Traber DL (1994) Effects of nitric oxide synthesis inhibition in hyperdynamic endotoxemia. Crit Care Med 22: 306 – 312

    Article  PubMed  CAS  Google Scholar 

  • Moncada S, Higgs A (1993) The L–arginine–nitric oxide pathway. N Eng J Med 329: 2202 – 2212

    Google Scholar 

  • Moore WM, Webber RK, Jerome GM, Tjoeng FS, Misko TP, Currie MD (1994) L-N6- (l-iminoethyl)lysine: a selective inhibitor of inducible nitric oxide synthase. J Med Chem 37: 3886 – 3888

    Article  PubMed  CAS  Google Scholar 

  • Morris SM, Billiar TR (1994) New insights into the regulation of inducible nitricoxide synthase. Am J Physiol 266: E829-E839 Nathan C (1992)

    Google Scholar 

  • Nitric oxide as a secretory product of mammalian cells. FASEB J 6: 3051–3064

    Google Scholar 

  • Nathanson C, Hoffmann WD, Suffredini EF, Eichacker PQ, Danner RL (1994) Selected treatment strategies for septic shock based on proposed mechanism of pathogenesis. Ann Intern Med 120: 771 – 783

    Google Scholar 

  • Park KS, Lee HW, Hong SY (1988) Determination of methylated amino acids in human serum by high-performance liquid chromatography. J Chromatography 440: 225 – 230

    Article  CAS  Google Scholar 

  • Parillo JE (1990) Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction and therapy. Ann Intern Med 113:227–242 Petros A, Bennett D, Vallance P (1991) Effect of nitric oxide synthase inhibitors on

    Google Scholar 

  • hypotension in patients with septic shock. The Lancet 338:1557–1558 Petros A, Lamb G, Leone A, Moncada S, Bennett D, Vallance P (1994) Effects of a nitric oxide synthase inhibitor in humans with septic shock. Cardiovasc Res 28: 34–39

    Google Scholar 

  • Preiser JC, Vincent JL (1996) Nitric oxide involvement in septic shock: Do human beings behave like rodents In: Vincent JL (ed) 1996 Yearbook of Intensive Care and Emergency Medicine Springer, Berlin, pp 358 – 365

    Google Scholar 

  • Rees DD (1995) Role of nitric oxide in the vascular dysfunction in septic shock. Biochem Soc Trans 23: 1025 – 1029

    PubMed  CAS  Google Scholar 

  • Rees DD, Cellek S, Palmer RMJ, Moncada S (1990) Dexamethasone prevents the induction of nitric oxide synthase and the associated effects on the vascular tone: an insight into endotoxic shock. Biochem Biophys Res Commun 173: 541 – 547

    Article  PubMed  CAS  Google Scholar 

  • Robertson FM, Offner PJ, Ciceri DP, Becker WK, Pruitt BA Jr (1994) Detrimental hemodynamic effects of nitric oxide synthase inhibition in septic shock. Arch Surg 129: 149 – 155

    PubMed  CAS  Google Scholar 

  • Ruetten H, Southan GJ, Abate A, Thiemermann C (1996) Attenuation of the multiple organ dysfunction caused by endotoxin by l-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 118: 261 – 270

    PubMed  CAS  Google Scholar 

  • Ruetten H, Southan GJ, Abate A, Thiemermann C (1996) Attenuation of the multiple organ dysfunction caused by endotoxin by l-amino-2-hydroxy-guanidine, a potent inhibitor of inducible nitric oxide synthase. Br J Pharmacol 118: 261 – 270

    PubMed  CAS  Google Scholar 

  • Seo HG, Fujiwara N, Kaneto H, Asashi M, Fujii J, Taniguchi N (1996) Effect of the nitric oxide synthase inhibitor, S-ethyl-isothiourea, on cultured cells and cardiovascular functions of normal and lipopolysaccharide-treated rabbits. J Biochem 119: 553 – 558

    PubMed  CAS  Google Scholar 

  • Southan G, Szabo C, Thiemermann C (1995) Isothioureas: potent inhibitors of nitricoxide synthases with variable isoform selectivity. Br J Pharmacol 114: 510 – 516

    PubMed  CAS  Google Scholar 

  • Southan GJ, Szabo C (1996) Selective pharmacological inhibition of distinct nitricoxide synthase isoforms. Biochem Pharmacol 51: 383 – 394

    Article  PubMed  CAS  Google Scholar 

  • Southan GJ, Szabo C, O’Conner MP, Salzman AC, Thiemermann C (1996) Amidines are potent inhibitors of constitutive and inducible nitric oxide synthases: Preferential inhibition of the inducible isoform. Eur J Pharmacol 291: 311 – 318

    Google Scholar 

  • Sprong RC, Aarsman CJM, Oirschot JFLM, Asbeck BS (1997) Dimethylthiourea protects rats against gram–negative sepsis and decreases tumour necrosis factor and nuclear factor KB activity. J Lab Clin Med 129:470–481 Strohmeier W, Werner ER, Redl H, Wachter H, Schlag G (1995) Plasma nitrate and pteridine levels in experimental bacteremia in baboons. Pteridines 6: 8 – 11

    Google Scholar 

  • Szabo C, Southan G, Thiemermann C (1994) Beneficial effects and improved survival in rodent models of septic shock with S-methyl-isothiourea sulfate, a novel, potent and selective inhibitor of inducible nitric oxide synthase. Proc Natl Acad Sci USA 91: 12472 – 12476

    Article  PubMed  CAS  Google Scholar 

  • Szabo C, Thiemermann C (1995) Regulation of the expression of the inducible isoform of nitric oxide synthase. Adv Pharmacol 34: 113 – 154

    Article  PubMed  CAS  Google Scholar 

  • Thiemermann C (1994) The role of L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28: 45 – 79

    Article  PubMed  CAS  Google Scholar 

  • Thiemermann C (1994) The role of L-arginine: nitric oxide pathway in circulatory shock. Adv Pharmacol 28: 45 – 79

    Article  PubMed  CAS  Google Scholar 

  • Thiemermann C, Vane JR (1990) Inhibition of nitric oxide synthesis reduces the hypotension induced by bacterial lipopolysaccharide in the rat. Eur J Pharmacol 182: 591 – 595

    Article  PubMed  CAS  Google Scholar 

  • Walder CE, Thiemermann C, Vane JR (1991) The involvement of endothelium - derived relaxing factor in the regulation of renal cortical blood flow in the rat. Br J Pharmacol 102: 967 – 973

    PubMed  CAS  Google Scholar 

  • Walker TA, Curtis SE, King-VanVlack CE, Chapler CK, Vallet B, Cain SM (1995) Effects of nitric oxide synthase inhibition on regional hemodynamics and oxygen transport in endotoxic dogs. Shock 4: 415 – 420

    PubMed  CAS  Google Scholar 

  • Waurick R, Bone HG, Meyer J, Booke M, Meissner A, Prien T, Van Aken H (1997) Haemodynamic effects of dopexamine and nitric oxide synthase inhibition in healthy and endotoxaemic sheep. Eur J Pharmacol 333: 181 – 186

    Article  PubMed  Google Scholar 

  • Wei X, Charles IG, Smith A (1995) Altered immune responses in mice lacking inducible nitric oxide synthase. Nature 375: 408 – 411

    Article  PubMed  CAS  Google Scholar 

  • Wolff DJ, Lubeskie A (1995) Aminoguanidine is an isoform-selective, mechanism-based inactivator of nitric oxide synthase. Arch Biochem Biophys 316: 290 – 301

    Article  PubMed  CAS  Google Scholar 

  • Wu CC, Chen SJ, Szabo C, Thiemermann C, Vane JR (1995) Aminoguanidine attenuates the delayed circulatory failure and improves survival in rodent models of endotoxic shock. Br J Pharmacol 114: 1666 – 1672

    PubMed  CAS  Google Scholar 

  • Wu CC, Ruetten H, Thiemermann C (1996) Comparison of the effects of aminoguanidine and NG-nitro-L-arginine methylester on the multiple organ dysfunction caused by endotoxaemia in the rat. Eur J Pharmacol 300: 99 – 104

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. Thiemermann
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Institut für Immunologie der Universität Wien, Borschkegasse 8 a, 1090, Wien, Austria

    Martha M. Eibl

  2. Department of Hematology, Johannes Gutenberg Universität, Langenbeckstr. 1, 55101, Mainz, Germany

    Christoph Huber

  3. Abteilung Für Rheumatologie und Klinische Immunologie, Medizinische Universitätsklinik, Hugstetter Str. 55, 79106, Freiburg, Germany

    Hans H. Peter

  4. Pädiatrische Pneumologie und Immunologie, Universitäts-Klinikum Rudolf-Virchow Standort Charlottenburg, Heubnerweg 6, 14059, Berlin, Germany

    Ulrich Wahn

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Thiemermann, C. (1999). Nitric Oxide, Systemic Inflammatory Response Syndrome and Circulatory Shock. In: Eibl, M.M., Huber, C., Peter, H.H., Wahn, U. (eds) Symposium in Immunology VIII. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-59947-7_5

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-59947-7_5

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-64722-5

  • Online ISBN: 978-3-642-59947-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation